Reference : Towards a European strategy to address the COVID-19 pandemic

	Document type :	Scientific journals : Article
	Discipline(s) :	Life sciences : Multidisciplinary, general & others Human health sciences : Immunology & infectious disease Human health sciences : Multidisciplinary, general & others
	Focus Areas :	Systems Biomedicine
	To cite this reference:	http://hdl.handle.net/10993/47800

Title :	Towards a European strategy to address the COVID-19 pandemic
Language :	English
Author, co-author :	Priesemann, V. [> >]
	Balling, Rudolf [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) >]
	Bauer, S. []
	Beutels, P. [> >]
	Valdez, A. C. [> >]
	Cuschieri, S. [> >]
	Czypionka, T. [> >]
	Dumpis, U. [> >]
	Glaab, Enrico [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Biomedical Data Science]
	Grill, E. [> >]
	Hotulainen, P. [> >]
	Iftekhar, E. N. [> >]
	Krutzinna, J. [> >]
	Lionis, C. [> >]
	Machado, H. [> >]
	Martins, C. [> >]
	McKee, M. [> >]
	Pavlakis, G. N. [> >]
	Perc, M. [> >]
	Petelos, E. [> >]
	Pickersgill, M. [> >]
	Prainsack, B. [> >]
	Schernhammer, E. [> >]
	Szczurek, E. [> >]
	Tsiodras, S. [> >]
	Van Gucht, S. [> >]
	Willeit, P. [> >]
Publication date :	In press
Journal title :	The Lancet
Peer reviewed :	Yes
Audience :	International
Keywords :	[en] COVID-19 ; SARS-CoV-2 ; expert survey ; Delphi study ; group forecast ; non-pharmaceutical interventions
Abstract :	[en] How will the coronavirus disease 2019 (COVID-19) pandemic develop in the coming months and years? Based on an expert survey, we examine key aspects that are likely to influence the COVID-19 pandemic in Europe. The challenges and developments will strongly depend on the progress of national and global vaccination programs, the emergence and spread of variants of concern (VOCs), and public responses to non-pharmaceutical interventions (NPIs). In the short term, many people remain unvaccinated, VOCs continue to emerge and spread, and mobility and population mixing are expected to increase. Therefore, lifting restrictions too much and too early risk another damaging wave. This challenge remains despite the reduced opportunities for transmission given vaccination progress and reduced indoor mixing in summer 2021. In autumn 2021, increased indoor activity might accelerate the spread again, whilst a necessary reintroduction of NPIs might be too slow. The incidence may strongly rise again, possibly filling intensive care units, if vaccination levels are not high enough. A moderate, adaptive level of NPIs will thus remain necessary. These epidemiological aspects combined with economic, social, and health-related consequences provide a more holistic perspective on the future of the COVID-19 pandemic.
Research centres :	Luxembourg Centre for Systems Biomedicine (LCSB): Biomedical Data Science (Glaab Group)
Funders :	Fonds National de la Recherche - FnR
Name of the research project :	CovScreen > Combined In Silico Molecular Docking And In Vitro Experimental Assessment Of Drug Repurposing Candidates For Covid-19 > 01/06/2020 > 30/11/2020 > 2020
Target :	Researchers ; Professionals ; Students
Permalink :	http://hdl.handle.net/10993/47800
DOI :	10.1016/S0140-6736(21)01808-0
Other URL :	https://doi.org/10.1016/S0140-6736(21)01808-0
Mentions required by the publisher for OA :	The original publication is available at https://doi.org/10.1016/S0140-6736(21)01808-0
Commentary :	in press
FnR project :	FnR ; FNR14715687 > Enrico Glaab > CovScreen > Combined In Silico Molecular Docking And In Vitro Experimental Assessment Of Drug Repurposing Candidates For Covid-19 > 01/06/2020 > 30/11/2020 > 2020

	File(s) associated to this reference
	Fulltext file(s): File Commentary Version Size Access Open access PIIS0140673621018080.pdf Publisher postprint 55.73 kB View/Open

All documents in ORBi^lu are protected by a user license.

 

University of Luxembourg Library |  Feedback |  Legal notices Site Map